Catyalyst Pharmaceutical (CPRX) Posts Narrower than Expected Q1 Loss
Tweet
Share
E-mailGet Alerts CPRX Hot Sheet
Price: $31.39 +0.03%
EPS Growth %: -30.9%
Financial Fact:
Research and development: 2.49M
Today's EPS Names:
OCCI, MAYS, CRMT, More
EPS Growth %: -30.9%
Financial Fact:
Research and development: 2.49M
Today's EPS Names:
OCCI, MAYS, CRMT, More
Join SI Premium – FREE
Catyalyst Pharmaceutical Partners (NASDAQ: CPRX) reported Q1 EPS of ($0.04), $0.04 better than the analyst estimate of ($0.08).
For earnings history and earnings-related data on Catyalyst Pharmaceutical Partners (CPRX) click here.
For earnings history and earnings-related data on Catyalyst Pharmaceutical Partners (CPRX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Ennis (EBF) Reports In-Line Q1 EPS
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Incyte settles CMS lawsuit over Opzelura Medicaid rebate rules
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
